Back

Clinical Characteristics of Recurrent-positive Coronavirus Disease 2019 after Curative Discharge: a retrospective analysis of 15 cases in Wuhan China

Chen, L.; Zhang, Z.-Y.; Zhang, X.-B.; Zhang, S.-Z.; Han, Q.-Y.; Feng, Z.-P.; Fu, J.-G.; Xiao, X.; Chen, H.-M.; Liu, L.-L.; Chen, X.-L.; Lan, Y.-P.; Zhong, D.-J.; Hu, L.; Wang, J.-H.; Yin, Z.-Y.

2020-07-04 infectious diseases
10.1101/2020.07.02.20144873 medRxiv
Show abstract

In China, the patients with previously negative RT-PCR results again test positive during the post-discharge isolation period. We aimed to determine the clinical characteristics of these "recurrent-positive" patients. We retrospectively reviewed the data of 15 recurrent-positive patients and 107 control patients with non-recurrent, moderate COVID-19 treated in Wuhan, China. Clinical data and laboratory results were comparatively analyzed. We found that recurrent-positive patients had moderate disease. The rate of recurrent-positive disease in our hospital was 1.87%. Recurrent-positive patients were significantly younger (43(35-54) years) than control patients (60(43-69) years) (P=0.011). The early LOS (length of stay in hospital before recurrence) was significantly longer in recurrent-positive patients (36(34-45) days) than in control patients (15(7-30) days) (P =0.001). The time required for the first conversion of RT-PCR results from positive to negative was significantly longer in recurrent-positive patients (14(10-17) days) than in control patients (6(3-9) days) (P =0.011). Serum COVID-19 antibody levels were significantly lower in recurrent-positive patients than in control patients (IgM: 13.69 {+/-} 4.38 vs. 68.10 {+/-} 20.85 AU/mL, P = 0.015; IgG: 78.53 {+/-} 9.30 vs. 147.85 {+/-} 13.33 AU/mL, P < 0.0001). Recurrent-positive patients were younger than control patients. The early LOS (length of stay in hospital before recurrence) was significantly longer in recurrent-positive group than that in control group. COVID-19 IgM/IgG antibody levels were significantly lower in recurrent-positive group than those in control group, which might explain why the virus RNA RT-PCR was positive after the initial "clinical cure"(with three times of virus RNA RT-PCR negative). The virus might not be fully eliminated because of the lower IgG level and their later replicating might result in recurrent-positive virus RNA RT-PCR.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Journal of Medical Virology
137 papers in training set
Top 0.2%
8.5%
2
PLOS ONE
4510 papers in training set
Top 25%
6.9%
3
International Journal of Infectious Diseases
126 papers in training set
Top 0.1%
6.9%
4
BioMed Research International
25 papers in training set
Top 0.3%
6.4%
5
Journal of Clinical Medicine
91 papers in training set
Top 0.5%
6.4%
6
Frontiers in Medicine
113 papers in training set
Top 1.0%
4.4%
7
Journal of Infection and Chemotherapy
16 papers in training set
Top 0.1%
4.3%
8
Clinical Infectious Diseases
231 papers in training set
Top 1%
4.3%
9
Journal of Clinical Virology
62 papers in training set
Top 0.2%
3.7%
50% of probability mass above
10
Virologica Sinica
10 papers in training set
Top 0.1%
3.7%
11
Scientific Reports
3102 papers in training set
Top 36%
3.6%
12
Journal of Infection and Public Health
15 papers in training set
Top 0.1%
2.1%
13
Frontiers in Neurology
91 papers in training set
Top 3%
1.7%
14
Epidemiology and Infection
84 papers in training set
Top 2%
1.5%
15
Medicine
30 papers in training set
Top 1%
1.3%
16
Frontiers in Microbiology
375 papers in training set
Top 7%
1.2%
17
Eurosurveillance
80 papers in training set
Top 1%
1.2%
18
JMIR Public Health and Surveillance
45 papers in training set
Top 3%
1.1%
19
Journal of Infection
71 papers in training set
Top 2%
1.0%
20
International Immunopharmacology
15 papers in training set
Top 0.3%
1.0%
21
eLife
5422 papers in training set
Top 51%
1.0%
22
Annals of Translational Medicine
17 papers in training set
Top 1%
1.0%
23
Journal of Translational Medicine
46 papers in training set
Top 2%
0.9%
24
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.9%
25
BMC Infectious Diseases
118 papers in training set
Top 5%
0.8%
26
Emerging Infectious Diseases
103 papers in training set
Top 3%
0.8%
27
Clinical Microbiology and Infection
60 papers in training set
Top 1%
0.8%
28
Microbiology Spectrum
435 papers in training set
Top 5%
0.8%
29
Frontiers in Public Health
140 papers in training set
Top 8%
0.8%
30
Journal of Clinical Investigation
164 papers in training set
Top 7%
0.7%